ArticleThe journal of prevention of Alzheimer's disease2025

Patient eligibility for amyloid-targeting immunotherapies in Alzheimer's disease.

Jurij Rosen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.